The itch-scratch cycle — understanding and breaking it permanently

The itch-scratch cycle is so central to eczema that it's sometimes treated as simply "what eczema is" — an inevitable loop that you manage as best you can. But the cycle has a specific biology, and understanding the mechanism reveals several points at which it can be interrupted.

The biology of itch in eczema

Itch in eczema is mediated primarily by a molecule called interleukin-31 (IL-31), a cytokine produced by Th2 immune cells that binds directly to itch receptors on sensory nerve fibres in the skin. IL-31 levels are elevated in eczema, which is why the itch is chronic and intense even when the skin looks relatively clear.

A separate itch mechanism involves histamine, released by mast cells in the skin in response to allergen exposure, heat, and pressure. Antihistamines work on this pathway — which is why they provide some relief — but IL-31 mediated itch doesn't respond to antihistamines, which explains why antihistamines often work poorly for eczema itch overall.

What scratching does

Scratching provides brief relief by temporarily overwhelming the itch signal — the sensation of scratching competes with and briefly displaces the itch sensation. But it causes several problems that perpetuate the cycle.

Mechanical trauma from scratching activates keratinocytes — the primary cells of the outer skin layer — to release more inflammatory cytokines, including more IL-31. More IL-31 means more itch. Scratching also damages the skin barrier directly, creating micro-fissures that allow allergens to enter, triggering more immune activation and more histamine release.

Scratching at night during sleep is a particular problem because it occurs without conscious awareness. People wake having scratched significantly without knowing it, and the skin has been damaged and inflamed while the barrier repair process of sleep was supposed to be occurring.

Interrupting the cycle: physical barriers

The most immediate intervention is a physical one — creating a barrier between fingernails and skin. Wearing cotton gloves at night reduces the damage of night scratching. Keeping fingernails very short reduces the trauma when scratching does occur. Wet wrapping creates both a physical barrier and a cooling effect that reduces itch intensity.

Interrupting the cycle: cooling

Cold reduces itch by activating a different set of nerve receptors — TRPM8 receptors — that effectively compete with and suppress the itch signal. A cool, damp cloth applied to an itching area produces immediate relief. Cool (not cold) showers or baths reduce generalised itch. Keeping the bedroom cool at night reduces the heat-triggered itch component that worsens most people's night symptoms.

Interrupting the cycle: topical treatments

Emollients applied frequently reduce itch by hydrating the skin and reducing the barrier permeability that allows allergens to trigger mast cells. Applying emollient to itching skin before scratching — using rubbing or patting motions rather than scratching — can blunt the urge while avoiding the barrier damage of scratching.

Topical calcineurin inhibitors — tacrolimus and pimecrolimus — work specifically on the T-cell mediated inflammation driving IL-31 production. They're useful for face and eyelid eczema where steroids can't be used long-term.

Interrupting the cycle: habit reversal

Scratching is partly habitual — a behaviour with a trigger (itch), a routine (scratching), and a reward (brief relief). Habit reversal training, developed in psychology, replaces the scratching routine with a competing response — pressing firmly on the itching area with the palm, applying emollient, or moving to a different location. Studies have shown significant reductions in scratching behaviour with consistent habit reversal practice over four to six weeks.

Interrupting the cycle at the source

All the above interventions address the cycle once it's established. The most effective long-term approach is to reduce the underlying immune activation driving IL-31 production — which means barrier repair and trigger elimination. When fewer allergens are entering through the barrier, less IL-31 is produced, the itch is less intense, and the cycle is easier to interrupt.